VITAL METALS WKN: A0F5YD ISIN: AU000000VML1 Kürzel: VJF Forum: Aktien Thema: Hauptdiskussion
VITAL METALS’ DECEMBER 2023 QUARTERLY REPORT Highlights Tardiff drilling returns shallow high grades that remain open to the west, northwest and on the southern margins from 23 drillhole results completed in a 2023 resource definition drilling program (74 holes totaling 6,664 m) Results from resource conversion program at Tardiff; best results included: 56.0m at 1.2% TREO from 34.00m incl. 1.05m at 5.4% TREO within 2.16m at 4.8% TREO 79.7m at 1.5% TREO from 13.30m incl. 1.5m at 4.3% TREO within 3.0m at 3.3% TREO and 4.15m at 3.0% TREO 33.45m at 2.2% TREO from 47.00m incl. 3.85m at 3.3% TREO within 8.95m at 2.8% TREO; 31.76m at 2.1% TREO from 34.24m and 1.92m at 4.0% TREO from 88.76m; 23.85m at 2.0% TREO from 9.15m; and 15.50m at 2.7% TREO from 30.50m Latest results confirm Vital’s contention for shallow higher-grade expansion potential, with future drilling focus to augment and de-risk the mineral resource Assay results from the remaining 34 holes will be released throughout early 2024 Mineral Resource Estimate update due Q1CY24 Vital is developing Tardiff, one of the largest single rare earths deposits in the western World, estimated to contain 416,000 tonnes of neodymium and praseodymium (NdPr). CORPORATE Vital completes the issue of 588,917,200 shares to Shenghe Resources (Singapore) Pte Ltd, a wholly-owned subsidiary of Shenghe Resources Holding Co., Ltd. (Shenghe) at a subscription price of A$0.01 per share to raise approximately A$5.9 million (Tranche 1 Subscription). Shenghe joins Vital’s register as a investor with a 9.9% equity position in the Company. Vital is set to sell its stockpiled rare earth material to Shenghe for approximately A$2.6 million (Stockpile Sale Agreement) Vital is now funded to deliver into key milestones in 2024, including: Mineral Resource Estimate update for Nechalacho Rare Earth Project; Scoping Study for Tardiff to focus on potential processing scale and scalability together with product saleability and margin, informed by learnings and experience of Vital’s new equity partner and shareholder; Examine lithium exploration potential across the Nechalacho Project; and Permitting and integration studies with respect to integration throughout the broader rare earths supply chain. Vital fully paid ordinary shares (ASX:VML) reinstated to official quotation on ASX and recommenced trading.
|
|
Thema | ||
|---|---|---|---|
| 1 | ATOS Hauptdiskussion | +12,00 % | |
| 2 | Dax Prognose | +0,34 % | |
| 3 | Lilium Aktie | +859,73 % | |
| 4 | BIOXCEL THERAPEUT DL-,001 Hauptdiskussion | +25,88 % | |
| 5 | MICROSTRATEGY Hauptdiskussion | -3,72 % | |
| 6 | TESLA MOTORS Hauptdiskussion | +0,02 % | |
| 7 | Security der nächsten Generation | +100,27 % | |
| 8 | TILRAY INC. CL.2 DL-,0001 Hauptdiskussion | -1,52 % | |
| 9 | The Social Chain - Forum Hauptdiskussion | +101,96 % | |
| 10 | NEL ohne Spam | -4,09 % | Alle Diskussionen |
|
|
Thema | ||
|---|---|---|---|
| 1 | ATOS Hauptdiskussion | +12,00 % | |
| 2 | Lilium Aktie | +859,73 % | |
| 3 | BIOXCEL THERAPEUT DL-,001 Hauptdiskussion | +25,88 % | |
| 4 | MICROSTRATEGY Hauptdiskussion | -2,50 % | |
| 5 | TESLA MOTORS Hauptdiskussion | -0,01 % | |
| 6 | Security der nächsten Generation | +100,27 % | |
| 7 | NEL ohne Spam | -4,09 % | |
| 8 | The Social Chain - Forum Hauptdiskussion | +101,96 % | |
| 9 | TILRAY INC. CL.2 DL-,0001 Hauptdiskussion | -1,52 % | |
| 10 | Aethlon Medical, Inc. | +7,41 % | Alle Diskussionen |